JP2024057010A5 - - Google Patents

Download PDF

Info

Publication number
JP2024057010A5
JP2024057010A5 JP2024025657A JP2024025657A JP2024057010A5 JP 2024057010 A5 JP2024057010 A5 JP 2024057010A5 JP 2024025657 A JP2024025657 A JP 2024025657A JP 2024025657 A JP2024025657 A JP 2024025657A JP 2024057010 A5 JP2024057010 A5 JP 2024057010A5
Authority
JP
Japan
Prior art keywords
gel composition
cosmetic gel
permeation enhancer
composition
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024025657A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024057010A (ja
Filing date
Publication date
Priority claimed from JP2018558113A external-priority patent/JP2019509330A/ja
Application filed filed Critical
Publication of JP2024057010A publication Critical patent/JP2024057010A/ja
Publication of JP2024057010A5 publication Critical patent/JP2024057010A5/ja
Pending legal-status Critical Current

Links

JP2024025657A 2016-01-26 2024-02-22 アルファアドレナリン作動薬の組成物および使用 Pending JP2024057010A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662287391P 2016-01-26 2016-01-26
US62/287,391 2016-01-26
JP2018558113A JP2019509330A (ja) 2016-01-26 2017-01-26 アルファアドレナリン作動薬の組成物および使用
PCT/US2017/015181 WO2017132410A1 (en) 2016-01-26 2017-01-26 Compositions and uses of alpha-adrenergic agents
JP2022010224A JP2022058765A (ja) 2016-01-26 2022-01-26 アルファアドレナリン作動薬の組成物および使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022010224A Division JP2022058765A (ja) 2016-01-26 2022-01-26 アルファアドレナリン作動薬の組成物および使用

Publications (2)

Publication Number Publication Date
JP2024057010A JP2024057010A (ja) 2024-04-23
JP2024057010A5 true JP2024057010A5 (enExample) 2024-11-07

Family

ID=59398678

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018558113A Withdrawn JP2019509330A (ja) 2016-01-26 2017-01-26 アルファアドレナリン作動薬の組成物および使用
JP2022010224A Pending JP2022058765A (ja) 2016-01-26 2022-01-26 アルファアドレナリン作動薬の組成物および使用
JP2024025657A Pending JP2024057010A (ja) 2016-01-26 2024-02-22 アルファアドレナリン作動薬の組成物および使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2018558113A Withdrawn JP2019509330A (ja) 2016-01-26 2017-01-26 アルファアドレナリン作動薬の組成物および使用
JP2022010224A Pending JP2022058765A (ja) 2016-01-26 2022-01-26 アルファアドレナリン作動薬の組成物および使用

Country Status (7)

Country Link
US (4) US10828252B2 (enExample)
EP (1) EP3407976A4 (enExample)
JP (3) JP2019509330A (enExample)
CN (2) CN115006537A (enExample)
AU (3) AU2017211793B2 (enExample)
CA (1) CA3012660A1 (enExample)
WO (1) WO2017132410A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120225918A1 (en) 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
CN115006537A (zh) 2016-01-26 2022-09-06 利维申制药有限公司 α-肾上腺素能药剂的组合物和用途
JP2020500220A (ja) 2016-11-15 2020-01-09 クラリア ファーマ ホールディング エービー 医薬製剤
WO2018170132A1 (en) 2017-03-14 2018-09-20 University Of Connecticut Biodegradable pressure sensor
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
KR20250099416A (ko) 2018-03-02 2025-07-01 퀀텀사이트, 인크. 조직으로부터 관심 영역의 단리 및 발현 분석을 위한 방법, 조성물, 및 장치
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
EP3880754A1 (en) * 2018-11-15 2021-09-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Lactide containing polyester-polyethylene glycol triblock thermoresponsive copolymers
US11826495B2 (en) 2019-03-01 2023-11-28 University Of Connecticut Biodegradable piezoelectric ultrasonic transducer system
US10814001B1 (en) 2019-05-06 2020-10-27 Rvl Pharmaceuticals, Inc. Oxymetazoline compositions
WO2021183626A1 (en) 2020-03-10 2021-09-16 University Of Connecticut Therapeutic bandage
US12491290B2 (en) 2020-06-08 2025-12-09 University Of Connecticut Biodegradable piezoelectric composite materials
CN112791033A (zh) * 2020-12-30 2021-05-14 广东蕾琪化妆品有限公司 一种新型眼影及其制备方法
US20240225978A1 (en) * 2021-01-23 2024-07-11 Christine Lynn Bokman Methods and compositions for pharmacological treatment of blepharoptosis
CN113149022B (zh) * 2021-04-30 2022-07-22 南昌大学 一种二氧化硅@硅酸钙中空纳米球及其制备方法和应用
US11779553B1 (en) * 2022-11-28 2023-10-10 Atif B. D. Collins Methods and devices for treatment of eyelid ptosis

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2784127A (en) 1954-06-02 1957-03-05 Eastman Kodak Co Plasticized monomeric adhesive compositions and articles prepared therefrom
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3993073A (en) 1969-04-01 1976-11-23 Alza Corporation Novel drug delivery device
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3731683A (en) 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
US3921636A (en) 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US3972995A (en) 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
US4230105A (en) 1978-11-13 1980-10-28 Merck & Co., Inc. Transdermal delivery of drugs
US4291015A (en) 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4444933A (en) 1982-12-02 1984-04-24 Borden, Inc. Adhesive cyanoacrylate compositions with reduced adhesion to skin
US4757128A (en) 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
US5462990A (en) 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US5633009A (en) 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
BR9306038A (pt) 1992-02-28 1998-01-13 Univ Texas Hidrogéis biodegradáveis fotopolimerizáveis como materiais de contato de tecidos e condutores de liberação controlada
US5665378A (en) 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5654381A (en) 1995-06-16 1997-08-05 Massachusetts Institute Of Technology Functionalized polyester graft copolymers
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US5628863A (en) 1996-06-12 1997-05-13 Lee; Shu-Ken Pouch producing machine
US5869090A (en) 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6312612B1 (en) 1999-06-09 2001-11-06 The Procter & Gamble Company Apparatus and method for manufacturing an intracutaneous microneedle array
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
KR20120035220A (ko) * 2003-01-22 2012-04-13 센주 세이야꾸 가부시키가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
CA2650592A1 (en) * 2006-04-26 2007-11-08 Aciex, Inc. Compositions for the treatment and prevention of eyelid swelling
US8366677B2 (en) 2007-08-06 2013-02-05 Transderm, Inc. Microneedle arrays formed from polymer films
MX2010005012A (es) * 2007-11-08 2010-06-23 Aciex Therapeutics Inc Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
US8633181B2 (en) * 2009-04-09 2014-01-21 Rutgers, The State University Of New Jersey Treatment of cutaneous hemangioma
EP2493475A4 (en) * 2009-10-30 2014-10-29 Intratus Inc COSMETIC METHODS AND PREPARATIONS FOR THE PROLONGED RELEASE OF THERAPEUTIC AGENTS IN THE EYE
CA2819633C (en) 2010-12-03 2019-04-23 Allergan, Inc. Pharmaceutical cream compositions and methods of use
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
KR20140074883A (ko) 2011-07-14 2014-06-18 알러간, 인코포레이티드 옥시메타졸린의 겔 조성물들 및 사용 방법
US20130035338A1 (en) * 2011-08-05 2013-02-07 Gordon Tang Eyelid treatment
CN104302349B (zh) 2012-03-16 2018-06-05 新加坡国立大学 制造聚合物微针的新方法
JP2015521910A (ja) 2012-06-29 2015-08-03 イーエルシー マネージメント エルエルシー １つ以上の封入された化粧品成分を含む可溶性マイクロニードル
WO2015191917A1 (en) 2014-06-11 2015-12-17 Allergan, Inc. Stabilized oxymetazoline formulations and their uses
US20190000808A1 (en) 2015-07-13 2019-01-03 Allergan, Inc. Composition and methods for the treatment of blephopharoptosis
CN115006537A (zh) 2016-01-26 2022-09-06 利维申制药有限公司 α-肾上腺素能药剂的组合物和用途

Similar Documents

Publication Publication Date Title
JP2024057010A5 (enExample)
JP2022058765A5 (enExample)
RU2245715C2 (ru) Композиция лака для ногтей
US20170112780A1 (en) Pharmaceutical composition for application to nail
JP6045663B2 (ja) 爪の成長速度を増大するためのキトサンの使用
JP2002512187A (ja) 爪真菌病の処置のための局所製剤
JPWO2019149450A5 (enExample)
JP2016512246A5 (enExample)
WO2007094999A2 (en) Ungual antifungal compositions
US20030012749A1 (en) Preparations for the non-traumatic excision of a nail
EP2968197B1 (fr) Composition filmogène et son utilisation pour le traitement des affections cutanées
JP2004532268A (ja) 異常な角質性物質を除去するための製剤
KR20210065968A (ko) 심미적 피부 상태를 치료하기 위한 철 킬레이팅 화합물
EP3378474B1 (en) Composition for the use in the treatment of plantar hyperhidrosis predisposing to cutaneous fungal infection of the foot
US11154542B2 (en) Nail lacquer composition containing ciclopirox
WO2022182900A9 (en) Skin serum
TWM643368U (zh) 具有交聯聚合物結合雙層胜肽載體（dpls）之包覆結構
HK1158541A (en) Use of chitosans to increase nail growth rate
HK1158541B (en) Use of chitosans to increase nail growth rate
HK1133189B (en) Use of chitosans to increase nail growth rate
HK1053067B (en) Antimycotic nail varnish composition